AI assistant
Sending…
Microbot Medical Inc. — Director's Dealing 2014
Jan 29, 2014
33819_dirs_2014-01-29_c7e7d8ea-a261-4a99-b970-08da066991e7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2014-01-27
Reporting Person: MCGLYNN MARTIN M (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-01-27 | Common Stock | F | 50858 | $1.41 | Disposed | 1118774 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 17194 | Indirect |
Footnotes
F1: This is recorded as a Code F disposition because the shares were used by the reporting person to pay a tax liability incurred by him from the delivery of shares incident to the vesting of restricted stock units.
F2: Includes (1) 700,000 restricted stock units, with 175,000 of this vesting on each of June 14, 2014, June 14, 2015, June 14, 2016, and June 14, 2017; and (2) 135,333 restricted stock units vesting on January 27, 2015.
F3: Shares held in 401(k) account in accordance with issuer's employer-match policies.
More from Microbot Medical Inc.
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 5
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Apr 10